Skip to main content
Signal8

aTYR PHARMA INC (ATYR)

aTyr Pharma, Inc., a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, the company's research focuses on pioneering novel immunological pathways to address various medical conditions. Its primary investigational drug, efzofitimod, functions as a selective modulator of NRP2. This compound is currently undergoing a Phase III clinical trial for pulmonary sarcoidosis. Additionally, efzofitimod is being evaluated in a Phase 1b/2a clinical study for the treatment of other interstitial lung diseases (ILDs), including conditions such as chronic hypersensitivity pneumonitis and ILDs linked to connective tissue diseases. Beyond its lead candidate, aTyr Pharma's pipeline features ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase, which is in preclinical stages of development for combating fibrosis. The company is also progressing with ATYR0750, a domain sourced from alanyl-tRNA synthetase, intended for the management of liver disorders. Furthermore, aTyr Pharma has entered into a strategic collaboration and licensing agreement with Kyorin Pharmaceutical Co., Ltd. This partnership is focused on the development and commercialization of efzofitimod for interstitial lung diseases specifically within the Japanese market.

Sector: Biological Products, (No Diagnostic Substances)

Industry: Biotechnology

aTyr Pharma, Inc. logo

aTyr Pharma, Inc.

NASDAQ:ATYRHealthcare
-8.01%$4.94
AH$4.94+0.00%vs close
Mkt Cap-
Float2.44M
O/S-
Vol
$ Vol
RVOL
Inst Own39.5%
Earnings
Dilution
Financials Summary
Revenue$190K
Net Income-$74.12M
Total Assets$94.16M
Free Cash Flow-$62.06M
Debt & Equity
Debt 15%
Equity 85%
Total Debt$12.03M
Total Equity$67.48M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
2-year cumulative
1:40

Nasdaq bars a compliance period at 1:250

  1. 1:40Reverse split
    Oct 29, 202640 shares → 1
Balance Sheet Details
Assets$94.16M
Liabilities$26.88M
Accounts Receivable$873K
Accounts Payable$3.89M
Inventory$0
PP&E (Net)$10.38M
Goodwill$0
Intangible Assets$0
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Revenue$190K$235K$353K$10.39M$0$10.46M$422K$0$0$0$0$0$0$0
YoY Growth-19.1%-33.4%-96.6%--2377.5%--------
Cost of Revenue$1.55M$0$0$1.7M$1.3M$17.29M$14.05M$746K$713K$900K$0$0$0$540K
Gross Profit-$1.36M$235K$353K$8.69M-$1.3M-$6.84M-$13.63M-$746K-$713K-$900K$0$0$0-$540K
Gross Margin-717.4%100.0%100.0%83.7%--65.4%-3228.9%-------
Research and Development$60.22M$54.37M$42.29M$42.81M$23.26M$17.29M$14.05M$20.39M$30.07M$44.25M$34.5M$16.78M$13.83M$7.75M
Selling, General, and Administrative$17.6M$13.78M$12.98M$12.29M$10.75M$9.07M$9.35M$11.69M$16.36M$14.19M$13.11M$6.78M$5.71M$4.31M
Other-$1.55M$0$0$0-$1.3M-$17.29M-$14.05M$0$0$0$0$0$0$0
Total Operating Expenses$76.26M$68.15M$55.27M$55.09M$32.71M$9.07M$9.35M$32.07M$46.43M$58.44M$47.62M$23.55M$19.54M$12.06M
Operating Income (EBIT)-$77.63M-$67.91M-$54.92M-$46.4M-$34.02M-$15.91M-$22.98M-$32.82M-$47.15M-$59.34M-$47.62M-$23.55M-$19.54M-$12.6M
Operating Margin-40856.3%-28899.6%-15557.8%-446.8%--152.2%-5445.0%-------
Interest Expense$0$0$0$0$0$0$0$0$0$0$0$832K$444K$272K
Interest Income$0$0$0$0$0$0$0$0$0$65K$0$0$0$0
Other Income (Expense)$3.51M$3.89M$4.52M$1.06M$238K-$319K-$785K-$1.7M-$1.06M$1.44M-$357K-$796K-$472K-$261K
Income Before Tax (EBT)-$74.12M-$64.02M-$50.4M-$45.34M-$33.78M-$16.23M-$23.76M-$34.52M-$48.21M-$57.9M-$47.97M-$24.35M-$20.01M-$12.86M
Income Tax Expense$0$0$0$0$0$0$0$0$0-$49K$0$0$0$0
Net Income-$74.12M-$64.02M-$50.39M-$45.34M-$33.77M-$16.22M-$23.6M-$34.52M-$48.21M-$57.85M-$47.97M-$24.35M-$20.01M-$17.61M
Net Income Margin-39009.5%-27243.8%-14274.5%-436.5%--155.2%-5593.1%-------
Supplementary Data
EPS-0.80-0.86-0.94-1.60-1.77-1.77-7.03-16.13-26.16-34.20-42.42-422.73-429.90-0.45
Diluted EPS-0.80-0.86-0.94-1.60-1.77-1.77-7.03-16.13-26.16-34.20-42.42-415.63-397.39-0.45
Weighted Average OS92.99M74.26M53.61M28.42M19.08M9.16M3.36M2.14M1.84M1.69M1.13M58,58650,36339.42M
EBITDA-$72.56M-$62.48M-$47.66M-$43.65M-$32.47M-$14.64M-$21.61M-$32.07M-$46.43M-$57M-$45.35M-$22.73M-$18.83M-$12.05M
EBITDA Margin-38192.1%-26588.1%-13500.3%-420.3%--140.1%-5121.3%-------
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Assets
Current Assets
Cash and Cash Equivalents$10.74M$11.05M$22.54M$9.98M$2.34M$16.95M$9.21M$22.96M$21.09M$38.39M$53.02M$13.9M$36.46M$3.67M
Short-Term Investments$67.94M$61.07M$75.62M$56.16M$105.58M$14.74M$21.93M$26.58M$64.03M$33.76M$42.51M$1.95M$0$0
Cash and Short-Term Investments$78.69M$72.13M$98.17M$66.15M$107.91M$31.69M$31.14M$49.55M$85.12M$72.15M$95.53M$15.85M$36.46M$3.67M
Accounts Receivable$873K$1.74M$2.44M$11.78M$435K$2.04M$100K$0$0$0$0$0$0$0
Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Current Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$816K
Total Current Assets$80.24M$81.95M$102.99M$80.87M$113.57M$35.53M$31.93M$50.8M$86.98M$74.77M$97.95M$16.51M$37.02M$4.49M
Long-Term Assets
Property, Plant & Equipment Net$10.38M$11.86M$14.05M$11.56M$1.81M$2.98M$4.09M$1.85M$2.28M$1.42M$1.79M$1.93M$2.5M$2.58M
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Investments$2.23M$0$0$0$0$0$0$0$0$4M$29.81M$0$0$69K
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.31M$3.02M$3.62M$3.36M$158K$213K$172K$90K$90K$333K$118K$2.21M$260K$331K
Total Long-Term Assets$13.93M$14.88M$17.66M$14.91M$1.97M$3.19M$4.26M$1.94M$2.37M$5.76M$31.73M$4.13M$2.77M$2.98M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$94.16M$96.83M$120.65M$95.79M$115.54M$38.73M$36.19M$52.75M$89.36M$80.52M$129.68M$20.64M$39.79M$7.47M
Liabilities
Current Liabilities
Accounts Payable$3.89M$4.32M$3.53M$3.11M$1.03M$1.43M$847K$1.04M$2.28M$2.61M$3.87M$1.43M$1.05M$593K
Short-Term Debt$1.47M$0$0$0$0$0$8.74M$7.77M$5.01M$339K$3.37M$5.13M$728K$875K
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$208K$0$0$0$0$0$0$255K
Other Current Liabilities$6.8M$0$0$0$0$0$0$0$0$130K$315K$614K$2.02M$444K
Total Current Liabilities$15.15M$14.97M$16.42M$13.86M$6.01M$5.86M$12.92M$10.83M$10.39M$8.53M$12.15M$10.11M$5.21M$3.53M
Long-Term Liabilities
Long-Term Debt$0$0$0$0$0$0$0$8.26M$14.72M$9.2M$1.78M$5.14M$6.16M$3.67M
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$1.02M
Long-Term Deferred Tax Liabilities$1.16M$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$0$0$0$0$0$0$0$0$0$0$701K$96.4M$94.5M$512K
Total Long-Term Liabilities$11.73M$12.03M$13.77M$10.64M$398K$1.38M$2.24M$8.26M$14.72M$9.2M$2.48M$101.54M$100.66M$5.2M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$26.88M$27M$30.18M$24.5M$6.41M$7.24M$15.16M$19.1M$25.11M$17.72M$14.63M$111.65M$105.87M$8.73M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$2K$2K$2K$0$0$0$0$63.23M
Common Stock$98K$84K$63K$29K$28K$11K$4K$31K$30K$24K$24K$1K$1K$6K
Retained Earnings-$606.16M-$532.05M-$468.02M-$417.63M-$372.3M-$338.53M-$322.3M-$298.7M-$264.19M-$215.98M-$158.12M-$110.15M-$85.8M-$64.52M
Comprehensive Income & Other-$8K-$40K-$74K-$433K-$263K-$43K-$40K-$60K-$120K-$76K-$171K-$69K-$69K$0
Other Stockholders' Equity$673.55M$601.98M$558.62M$489.07M$481.57M$370.17M$343.49M$332.32M$328.4M$278.76M$273.15M$19.14M$17.3M$63.23M
Total Equity$67.48M$70.02M$90.66M$71.46M$109.3M$31.65M$21.19M$33.65M$64.25M$62.8M$115.05M-$91.01M-$68.5M-$1.28M
Minority Interest-$192K-$187K-$188K-$180K-$175K-$166K-$160K$0$0$0$0$0$2.41M$25K
Total Liabilities and Equity$94.36M$97.02M$120.84M$95.97M$115.71M$38.89M$36.35M$52.75M$89.36M$80.52M$129.68M$20.64M$37.37M$7.44M
Supplementary Data
Total Debt$12.03M$13.28M$15.1M$11.53M$1.38M$2.24M$11.73M$16.03M$19.73M$9.54M$5.14M$10.28M$6.89M$4.54M
Net Debt$1.29M$2.23M-$7.45M$1.55M-$958K-$14.71M$2.52M-$6.93M-$1.36M-$28.85M-$47.88M-$3.62M-$29.57M$867K
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-31
Operating Activities
Net Income-$74.12M-$64.02M-$50.39M-$45.34M-$33.77M-$16.22M-$23.76M-$34.52M-$48.21M-$57.85M-$47.97M-$24.35M-$20.01M-$17.61M
Depreciation & Amortization$1.55M$1.54M$2.74M$1.7M$1.3M$1.27M$1.37M$746K$713K$900K$869K$829K$714K$540K
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$5M$2.99M$2.6M$2.15M$1.61M$1.47M$1.78M$0$0$0$4.86M$1.79M$155K$0
Changes in Working Capital:
  Accounts Receivable$863K$402K$9.05M-$11.92M$1.6M-$1.94M$58K$0$0$0$0$0$0$0
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable$0-$1.34M$3.26M$0$47K$1.76M$0-$2.06M-$2.49M$0$0$0$0$750K
  Other Working Capital$6.59M-$5.98M$2.7M$11.09M-$4.24M-$2.08M$148K$610K$761K-$1.35M$3.28M-$1.25M$1.85M$37K
Total Working Capital Change$7.45M-$6.92M$15.01M-$833K-$2.59M-$2.26M$206K-$1.45M-$1.73M-$1.35M$3.28M-$1.25M$1.85M$787K
Other Non-Cash Items-$1.87M-$2.71M-$3.19M$441K$363K$453K$395K$7.7M$10.78M$7.25M$2.17M$156K-$15K$4.9M
Net Cash from Operating-$61.99M-$69.12M-$33.22M-$41.89M-$33.08M-$15.3M-$20.01M-$31.06M-$42.36M-$52.86M-$36.8M-$22.82M-$17.31M-$11.38M
Investing Activities
Capital Expenditures-$77K-$65K-$4.21M-$1.64M-$192K-$202K-$79K-$594K-$1.31M-$600K-$664K-$249K-$644K-$598K
Acquisitions$12K$7K$0$0$50K$18K$0$0$0$0$0$0$0$0
Purchases of Investments-$93.44M-$69.1M-$106.98M-$42.12M-$126.51M-$21.07M-$40.65M-$40.3M-$77.67M-$28.09M-$109.44M-$5.4M$0$0
Sales of Investments$86.6M$86.39M$91.05M$90.83M$35.08M$28.15M$45.6M$78.06M$51.35M$62.22M$38.12M$3.4M$0$0
Other Investing Activities$1.85M$0$15K$179K$0$0$51K$0$0$0$0$0$0$0
Net Cash from Investing-$5.05M$17.23M-$20.13M$47.24M-$91.57M$6.9M$4.92M$37.17M-$27.64M$33.53M-$71.99M-$2.25M-$644K-$598K
Financing Activities
Debt Repaid$539K$497K$394K$66K-$9.08M$8M$4.67M-$9.87M-$4.53M$5.24M-$3.44M-$12M-$1.65M
Common Stock Issuance$66.42M$40.26M$66.52M$5.47M$109.95M$25.22M$9.32M$379K$42.48M$163K$76.9M$0$0$4K
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities$0$100K$105K$45K$73K$10K$13K$50K$361K$163K$0-$927K$77K$0
Net Cash from Financing$66.01M$39.86M$66.23M$5.45M$110.03M$16.14M$1.34M-$4.24M$52.7M$4.7M$147.92M$2.51M$50.74M$1.66M
Forex Effect$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash-$1.03M-$12.02M$12.88M$10.81M-$14.62M$7.74M-$13.75M$1.87M-$17.3M-$14.64M$39.13M-$22.56M$32.78M$0
Supplementary Data
Operating Cash Flow-$61.99M-$69.12M-$33.22M-$41.89M-$33.08M-$15.3M-$20.01M-$31.06M-$42.36M-$52.86M-$36.8M-$22.82M-$17.31M-$11.38M
Capital Expenditure-$77K-$65K-$4.21M-$1.64M-$192K-$202K-$79K-$594K-$1.31M-$600K-$664K-$249K-$644K-$598K
Free Cash Flow-$62.06M-$69.18M-$37.44M-$43.53M-$33.27M-$15.5M-$20.09M-$31.66M-$43.68M-$53.46M-$37.46M-$23.07M-$17.95M-$11.98M
Cash at Beginning$14.01M$26.03M$13.15M$2.34M$16.95M$9.21M$22.96M$21.09M$38.39M$53.02M$13.9M$36.46M$3.67M$0
Cash at End$12.98M$14.01M$26.03M$13.15M$2.34M$16.95M$9.21M$22.96M$21.09M$38.39M$53.02M$13.9M$36.46M$3.67M